Abstract
Some 4-(1,3-benzothiazol-2-yl)-benzoyl-1H-pyrazole derivatives have been synthesized by reaction of o-aminothiophenol (1) with different electrophilic and nucleophilic reagents. All of the newly synthesized compounds were evaluated for cytotoxicity against breast cancer cell line MCF-7. Two of the compounds were more potent than tamoxifen and three were as potent as tamoxifen. These results were consistent with percentage inhibition of human VEGF compared with control untreated cells.
Similar content being viewed by others
References
J. Folkman, Nat. Med. 1, 27 (1995)
R.S. Kerbel, Carcinogenesis 21, 505 (2005)
A.F. Karamysheva, Biochemistry 73, 751 (2008)
P. Carmeliet, Oncology 69, 4 (2005)
N. Ferrara, Oncology 69, 11 (2005)
M.R. Raspollini, G. Amunni, A. Villanucci, G. Baroni et al., Int. J. Gynecol. Cancer 14, 815 (2004)
R.D.R. Reis, E.C. Azevedo et al., Eur. J. Med. Chem. 46, 1448 (2011)
I. Caleta, M. Kralj, M. Marjanovic, B. Bertosa, S. Tomic, G. Pavlovic, K. Pavelic, G.K. Zamola, J. Med. Chem. 52(6), 1744 (2009)
J. Shukla, K. Hazra, P. Rashmi, L.V.G. Nargund, Der Chem. Sinici 2(3), 4 (2011)
C. Jimenez, Bioactive Nat. Prod. 25, 811 (2001)
G. Turan-Zitouni, S. Demirayak, A. Ozdemir, Z.A. Kaplancikli, M.T. Yildiz, Eur. J. Med. Chem. 39(3), 267 (2003)
Y.J. Cao, J.C. Dreixler, J.J. Couey, K.M. Houamed, Eur. J. Pharmacol. 449, 47 (2002)
A.D. Ramirez, S.K.F. Wong, F.S. Menniti, Eur. J. Pharmacol. 475, 29 (2003)
S.W. Gangadhar, B.C. Anil, N.B. Vijay, R.S. Giridhar, V.K. Sharad, J. Pharm. Res. 7, 823 (2013)
S. Sohail, R. Naghmana, G.J. Peter, A. Muhammad, H. Rizwan, Eur. J. Med. Chem. 45(4), 1323 (2010)
I. Hutchinson, S.A. Jennings, B.R. Vishnuvajjala, A.D. Westwell, M.F.G. Stevenes, J. Med. Chem. 45(3), 744 (2002)
C.O. Leong, M. Gaskell, E.A. Martin, R.T. Heydon, P.B. Farmer, M.C. Bibby, P.A. Cooper, J.A. Double, T.D. Bradshaw, M.F.G. Stevens, Br. J. Cancer 88, 470 (2003)
B.L. Eric, A.d-B. Monique, R.A.V. Thatyana, O.d-M. Manuel, C.M. Raquel, D.Y. Jwliane, Z.L. Kátia, Eur. J. Med. Chem. 86, 12 (2014)
D.F. Shi, T.D. Bradshaw, M.S. Chua, A.D. Westwell, M.F.G. Stevens, Bioorg. Med. Chem. Lett. 11, 1093 (2001)
R. Lin, G. Chiu, Y. Yu, P.J. Connolly et al., Bioorg. Med. Chem. Lett. 17(16), 4557 (2007)
G. Daidone, B. Maggio, D. Raffa, S. Plescia et al., IL Farmaco 59, 413 (2004)
A.A. Bekhit, T.A. El-Azim, Bioorg. Med. Chem. 12(8), 1935 (2004)
G. Menozzi, L. Merello, P. Fossa, L. Mosti et al., IL Farmaco 58(9), 795 (2003)
J.G. Varnes, D.A. Wacker, I.C. Jacobson, M.L. Quan et al., Bioorg. Med. Chem. Lett. 17, 6481 (2007)
T. Tanitame, Y. Oyamada, K. Ofuji, H. Terauchi et al., Bioorg. Med. Chem. Lett. 15(19), 4299 (2005)
E.Y. Song, N. Kaur, M.Y. Park, Y. Jin, K. Lee, G. Kim, K.Y. Lee, J.S. Yang, J.H. Shin, K.Y. Nam, K.T. No, G. Han, Eur. J. Med. Chem. 43, 1519 (2008)
R.M. Kumbhare, T. Dadmal, U. Kosurkar, V. Sridhar, J.V. Rao, Bioorg. Med. Chem. Lett. 22, 453 (2012)
K.M. Amin, M. El-Zahar, M.M. Anwar, M.M. Kamel, M.H. Mohamed, Acta Poloniae Pharm. Drug Res. 66(3), 279 (2009)
S. Shubhanjali, S. Radhey, K.S. Sushant, S. Ajit, K. Pankaj, Asian Pac. J. Trop. Biomed. 2(2), S1040 (2012)
I. Perkovic, I. Butula, M. Kralj, I. Martin-Kleiner, J. Balzarini, D. Hadjipavlou-Litina, A.-M. Katson, B. Zorc, Eur. J. Med. Chem. 51, 227 (2012)
I.F. Nassar, S.A. El-Assaly, Der Pharm. Chem. 3(1), 229 (2011)
A. Kumar, I. Ahmad, B.S. Chhikara, R. Tiwari, D. Mandal, K. Parang, Bioorg. Med. Chem. Lett. 21, 1342 (2011)
B.S. Holla, B. Veerendra, M.K. Shivananda, B. Poojary, Eur. J. Med. Chem. 38, 759 (2003)
S. Pautus, S.W. Yee, M. Jayne, M.P. Coogan, C. Simons, Bioorg. Med. Chem. 14, 3643 (2006)
P. Stoppie, M. Borgers, P. Borghgraef, L. Dillen et al., J. Pharmacol. Exp. Ther. 293(1), 304 (2000)
S.E.H. Wageeh, M.A. Kamelia, A.E.A. Samy, A.A.M. Eman, Der Pharma Chemica 3(6), 282 (2011)
P. Skehan, R. Storeng, D. Scudiero, A. Monks et al., J. Natl Cancer Inst. 82, 1107 (1990)
H.M. Verheul, E.E. Voest, R.O. Schlingemann, J. Pathol. 202, 5 (2004)
N. Ferrara, Nat. Rev. Cancer 2, 795 (2002)
J. Folkman, Nat. Rev. Drug Discov. 6, 273 (2007)
K.J. Gotink, H.M.W. Verheul, Angiogenesis 13, 1 (2010)
Acknowledgments
The authors gratefully acknowledge financial support from the Microanalytical Center, Faculty of Science, Cairo University, Egypt, by performing elemental analysis, IR, 1H NMR, and mass spectroscopy.
Conflict of interest
The authors have declared no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
El-Meguid, E.A.A., Ali, M.M. Synthesis of some novel 4-benzothiazol-2-yl-benzoyl-1H-pyrazoles, and evaluation as antiangiogenic agents. Res Chem Intermed 42, 1521–1536 (2016). https://doi.org/10.1007/s11164-015-2100-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-015-2100-8